» Articles » PMID: 21851590

A Phospho-proteomic Screen Identifies Substrates of the Checkpoint Kinase Chk1

Overview
Journal Genome Biol
Specialties Biology
Genetics
Date 2011 Aug 20
PMID 21851590
Citations 89
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The cell-cycle checkpoint kinase Chk1 is essential in mammalian cells due to its roles in controlling processes such as DNA replication, mitosis and DNA-damage responses. Despite its paramount importance, how Chk1 controls these functions remains unclear, mainly because very few Chk1 substrates have hitherto been identified.

Results: Here, we combine a chemical genetics approach with high-resolution mass spectrometry to identify novel Chk1 substrates and their phosphorylation sites. The list of targets produced reveals the potential impact of Chk1 function not only on processes where Chk1 was already known to be involved, but also on other key cellular events such as transcription, RNA splicing and cell fate determination. In addition, we validate and explore the phosphorylation of transcriptional co-repressor KAP1 Ser473 as a novel DNA-damage-induced Chk1 site.

Conclusions: By providing a substantial set of potential Chk1 substrates, we present opportunities for studying unanticipated functions for Chk1 in controlling a wide range of cellular processes. We also refine the Chk1 consensus sequence, facilitating the future prediction of Chk1 target sites. In addition, our identification of KAP1 Ser473 phosphorylation as a robust readout for Chk1 activity could be used to explore the in vivo effects of Chk1 inhibitors that are being developed for clinical evaluation.

Citing Articles

CHK1 controls zygote pronuclear envelope breakdown by regulating F-actin through interacting with MICAL3.

Zhang H, Cui Y, Yang B, Hou Z, Zhang M, Su W EMBO Rep. 2024; 25(11):4876-4897.

PMID: 39358552 PMC: 11549291. DOI: 10.1038/s44319-024-00267-7.


TRIM28 in cancer and cancer therapy.

Li K, Wang H, Jiang B, Jin X Front Genet. 2024; 15:1431564.

PMID: 39100077 PMC: 11294089. DOI: 10.3389/fgene.2024.1431564.


MATR3's Role beyond the Nuclear Matrix: From Gene Regulation to Its Implications in Amyotrophic Lateral Sclerosis and Other Diseases.

Santos J, Park J Cells. 2024; 13(11.

PMID: 38891112 PMC: 11171696. DOI: 10.3390/cells13110980.


Exploiting the DNA Damage Response for Prostate Cancer Therapy.

Stracker T, Osagie O, Escorcia F, Citrin D Cancers (Basel). 2024; 16(1).

PMID: 38201511 PMC: 10777950. DOI: 10.3390/cancers16010083.


Checkpoint kinase interaction with DNA polymerase alpha regulates replication progression during stress.

Hadjicharalambous A, Whale A, Can G, Skehel J, Houseley J, Zegerman P Wellcome Open Res. 2023; 8:327.

PMID: 37766847 PMC: 10521137. DOI: 10.12688/wellcomeopenres.19617.1.


References
1.
Chang C, Chou H, Lin Y, Huang K, Chang C, Hsu T . Phosphorylation at Ser473 regulates heterochromatin protein 1 binding and corepressor function of TIF1beta/KAP1. BMC Mol Biol. 2008; 9:61. PMC: 2474647. DOI: 10.1186/1471-2199-9-61. View

2.
Hickson I, Zhao Y, Richardson C, Green S, Martin N, Orr A . Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res. 2004; 64(24):9152-9. DOI: 10.1158/0008-5472.CAN-04-2727. View

3.
Brown E, Baltimore D . Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance. Genes Dev. 2003; 17(5):615-28. PMC: 196009. DOI: 10.1101/gad.1067403. View

4.
Paulsen R, Soni D, Wollman R, Hahn A, Yee M, Guan A . A genome-wide siRNA screen reveals diverse cellular processes and pathways that mediate genome stability. Mol Cell. 2009; 35(2):228-39. PMC: 2772893. DOI: 10.1016/j.molcel.2009.06.021. View

5.
Smith J, Tho L, Xu N, Gillespie D . The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv Cancer Res. 2010; 108:73-112. DOI: 10.1016/B978-0-12-380888-2.00003-0. View